Join Growin Stock Community!

Cellebrite di ltd.CLBT.US Overview

US StockTechnology
(No presentation for CLBT)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

CLBT AI Insights

CLBT Overall Performance

CLBT AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

CLBT Recent Performance

1.69%

Cellebrite di ltd.

0.66%

Avg of Sector

-0.31%

S&P500

CLBT PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

CLBT Key Information

CLBT Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

CLBT Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.

Price of CLBT

CLBT FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

CLBT Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.32
PE Ratio (TTM)
43.03
Forward PE
35.63
PS Ratio (TTM)
6.86
PB Ratio
6.73
Price-to-FCF
20.59
METRIC
VALUE
vs. INDUSTRY
Gross Margin
84.20%
Net Margin
16.47%
Revenue Growth (YoY)
18.56%
Profit Growth (YoY)
18.28%
3-Year Revenue Growth
20.29%
3-Year Profit Growth
20.81%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.32
PE Ratio (TTM)
43.03
Forward PE
35.63
PS Ratio (TTM)
6.86
PB Ratio
6.73
Price-to-FCF
20.59
Gross Margin
84.20%
Net Margin
16.47%
Revenue Growth (YoY)
18.56%
Profit Growth (YoY)
18.28%
3-Year Revenue Growth
20.29%
3-Year Profit Growth
20.81%

  • When is CLBT's latest earnings report released?

    The most recent financial report for Cellebrite di ltd. (CLBT) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating CLBT's short-term business performance and financial health. For the latest updates on CLBT's earnings releases, visit this page regularly.

  • Where does CLBT fall in the P/E River chart?

    According to historical valuation range analysis, Cellebrite di ltd. (CLBT)'s current price-to-earnings (P/E) ratio is 43.76, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of CLBT?

    According to the latest financial report, Cellebrite di ltd. (CLBT) reported an Operating Profit of 20.81M with an Operating Margin of 16.15% this period, representing a growth of 32.29% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is CLBT's revenue growth?

    In the latest financial report, Cellebrite di ltd. (CLBT) announced revenue of 128.82M, with a Year-Over-Year growth rate of 18.13%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does CLBT have?

    As of the end of the reporting period, Cellebrite di ltd. (CLBT) had total debt of 22.67M, with a debt ratio of 0.02. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does CLBT have?

    At the end of the period, Cellebrite di ltd. (CLBT) held Total Cash and Cash Equivalents of 124.46M, accounting for 0.13 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does CLBT go with three margins increasing?

    In the latest report, Cellebrite di ltd. (CLBT) achieved the “three margins increasing” benchmark, with a gross margin of 84.7%%, operating margin of 16.15%%, and net margin of 16.5%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess CLBT's profit trajectory and future growth potential.

  • Is CLBT's EPS continuing to grow?

    According to the past four quarterly reports, Cellebrite di ltd. (CLBT)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.09. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of CLBT?

    Cellebrite di ltd. (CLBT)'s Free Cash Flow (FCF) for the period is 82.86M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 36.4% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of CLBT?

    The latest valuation data shows Cellebrite di ltd. (CLBT) has a Price-To-Earnings (PE) ratio of 43.76 and a Price/Earnings-To-Growth (PEG) ratio of 6.73. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.